Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients

Taipei Medical University

Status: Unknown

Conditions: Lung Cancer Patients

Study type: Observational

Funder types: Other

Identifiers

NCT01257308

99047

Details and patient eligibility

About

We wants to analyse the EML4-ALK mutation rate in the patients who have non-small cell lung cancer.

Enrollment: 100 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 20 or more than 20 years of age
• The pathological diagnosis confirmed lung cancer
• Patients have achieved pleural effusion, or surgical biopsy to obtain tumor tissue specimens
• The patient had signed inform consent

Exclusion criteria

• pleural effusion or tumor tissue can not be obtained
• the patient is not suitable to join the research according to the judgement by the investigator